** Shares of India's Anthem BioSciences ANTH.NS rise 27% in trading debut to 726 rupees; shares were sold in the 540 rupees to 570 rupees price range in IPO
** Pharma co notches valuation of 408 bln rupees ($4.73 bln)
** Co's $395 million IPO, which was only a sale of shares by existing stakeholders, was fully subscribed last week
** Co - one of the leading global players in contract drugmaking and research - has made a strong debut, enjoys a niche place in the segment and leads pack of players - Shivani Nyati, Head of Wealth at Swastika Investmart
($1 = 86.2690 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))